Supplementary Figure 1 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer | Synapse
February 8, 2024Open Access
Supplementary Figure 1 from NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer
Key Points
Key points are not available for this paper at this time.